13779-42-5Relevant academic research and scientific papers
Preparation of compound with tanshinone IIA and phosphocreatine composite structure and application of compound in prevention of cardiovascular diseases
-
Paragraph 0020; 0029-0032, (2019/04/06)
The invention discloses a compound with tanshinone IIA and phosphocreatine composite structure, preparation of the compound, and application of the compound in medicine, and particularly relates to anovel compound shown as general formula (I) and its pharmaceutical salts (sodium salts, potassium salts and the like) or pharmaceutical compositions containing the novel compound, and a preparation method of the novel compound. The invention also discloses application of the compound or its pharmaceutical salts or the pharmaceutical composition containing the compound in the prevention and clinical treatment of cardiovascular diseases. The structural illustration of the general formula (I) is the same as definitions in the description.
HMG-COA REDUCTASE INHIBITORS
-
, (2008/06/13)
Disclosed are novel substituted cyclohexenyl phosphinylhydroxybutyrates as 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors useful as antihypercholesterolemic agents represented by the formula: STR1 and pharmaceutically acceptable salts ther
